GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
N

Novo Integrated Sciences NVOS · USD

Health Care · US listing · 🇺🇸 United States

Compare

0.00

+33.33%

Close of 9 Nov 2026, in USD

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

Price performance

Chart by TradingView, with its own licensed prices

Novo Integrated Sciences — daily NVOS Delayed
Market value
$15,784
Last close × shares
Volume
2.8k
Shares, 9 Nov 2026

About Novo Integrated Sciences

Its shares trade under the ticker NVOS. It has been listed since 12 July 2005. In the fiscal year to 31 August 2024, it reported revenue of $13.3m and a net loss of $16.1m. At that date it held total assets of $32.1m and shareholders' equity of $14.9m.

Novo Integrated Sciences Inc is a US-based company operating in Health Care Providers & Services industry. The company is headquartered in Bellevue, Washington. The company went IPO on 2005-07-12. Novo Integrated Sciences, Inc. is a parent company to its subsidiaries. The firm owns Canadian and United States subsidiaries that provide, or intend to provide, essential and differentiated solutions to the delivery of multidisciplinary primary care and related wellness products through the integration of medical technology, interconnectivity, advanced therapeutic, diagnostic solutions, personalized product offerings, and rehabilitative science. The firm operates through two segments: Healthcare Services and Product Sales. Its specialized multidisciplinary primary healthcare services include physiotherapy, chiropractic care, manual/manipulative therapy, occupational therapy, eldercare, massage therapy, acupuncture and functional dry needling, chiropody, stroke and traumatic brain injury/neurological rehabilitation, kinesiology, vestibular therapy, dietician and others. Its subsidiaries include Novo Healthnet Limited, Novomerica Health Group, Inc., PRO-DIP, LLC and others.

Figures and description from our data supplier, not checked against the company's own report.

More about Novo Integrated Sciences →

How it makes its money

Revenue, year to 31 Aug 2024

  • Healthcare Services [Member] $8.3m · 62.4%
  • Product Sales [Member] $4.9m · 37.0%
  • Corporate Segment [Member] $78,250 · 0.6%

Latest on Novo Integrated Sciences

Our reporting

We have not reported on Novo Integrated Sciences yet.

Other Health Care listings

Scenario calculator

Try your own numbers. This is arithmetic, not a forecast.

Interactive

Gain or loss

—

Return

—

Leaves out fees, taxes and financing.

Frequently asked questions

What is Novo Integrated Sciences's ticker?

Novo Integrated Sciences trades as NVOS on its US listing, under ISIN US67011T3005.

What was Novo Integrated Sciences's last closing price?

0.00 on 9 Nov 2026. The figure is in USD and is never converted.

Sources and methodology

Chart
TradingView
Close and company data
Our data supplier
News
Our reporting

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.